Key Developments: Atcor Medical Holdings Ltd (ACG.AX)

ACG.AX on Australia Stock Exchange

0.09AUD
11 Jul 2014
Price Change (% chg)

$-0.00 (-2.30%)
Prev Close
$0.09
Open
$0.09
Day's High
$0.09
Day's Low
$0.09
Volume
149,432
Avg. Vol
193,590
52-wk High
$0.22
52-wk Low
$0.07

Search Stocks

Latest Key Developments (Source: Significant Developments)

AtCor Medical Holdings Ltd gives FY 2014 guidance
Thursday, 3 Jul 2014 02:23am EDT 

AtCor Medical Holdings Ltd:Expects FY2014 revenue of about A$5.0 mln.Anticipates FY2014 net loss in range of A$2.2 mln to A$2.6 mln.  Full Article

AtCor Medical Holding Ltd announces patent grant in USA
Tuesday, 15 Apr 2014 08:08pm EDT 

AtCor Medical Holding Ltd:Says that a new patent 'Method for determination of cardiac output' has been granted in the USA.This establishes a position for AtCor in deriving cardiac output from central aortic pressure waveform and confers intellectual property rights to AtCor until Aug. 2026.  Full Article

Atcor Medical Holdings Ltd does not declare dividend
Thursday, 20 Feb 2014 12:30am EST 

Atcor Medical Holdings Ltd:Says no dividend has been declared for half-year ended Dec. 31, 2013.  Full Article

Health Canada approves Atcor Medical Holdings Ltd's SphygmoCor XCEL for sale in Canada
Tuesday, 28 Jan 2014 05:10pm EST 

Atcor Medical Holdings Ltd:Says that its SphygmoCor XCEL system has been approved by Health Canada, allowing the company to sell its new system to Canadian customers.  Full Article

Atcor Medical Holdings Ltd's SphygmoCor XCEL approved for sale in China
Monday, 13 Jan 2014 05:45pm EST 

Atcor Medical Holdings Ltd:Says that its SphygmoCor XCEL system has been approved by the China Food and Drug Administration (CFDA).Says its Chinese distributor, Angy (China) Medical Ltd, is now able to sell SphygmoCor XCEL to clinicians and researchers in mainland China.  Full Article

Atcor Medical Holdings Ltd Secures Pharmaceutical Trial Contract
Sunday, 27 Oct 2013 07:50pm EDT 

Atcor Medical Holdings Ltd announced that it has signed a new contract to supply SphygmoCor systems and clinical trial support services to a international pharmaceutical company. The minimum value of the contract, which includes a pre-negotiated option for contract expansion, is USD0.6 million. The study will be conducted in Germany.  Full Article

Atcor Medical Holdings Ltd Does Not Recommend Dividend
Sunday, 29 Sep 2013 10:25pm EDT 

Atcor Medical Holdings Ltd announced that the directors do not recommend payment of a dividend.  Full Article

Atcor Medical Holdings Ltd Does Not Declare Final Dividend
Thursday, 29 Aug 2013 07:14pm EDT 

Atcor Medical Holdings Ltd announced that no dividends have been declared or paid during or subsequent to the year ended June 30, 2013.  Full Article

Atcor Medical Holdings Ltd Issues FY 2013 Guidance
Sunday, 21 Jul 2013 07:35pm EDT 

Atcor Medical Holdings Ltd announced that for fiscal 2013, it expects to report a maiden profit in the range of $2.7-$2.9 million.  Full Article

Atcor Medical Holdings Ltd Announces European Patent Grant
Sunday, 14 Jul 2013 07:37pm EDT 

Atcor Medical Holdings Ltd announced that its European patent application, 'Method and apparatus for determination of central aortic pressure', has been successful. The patent, already granted in USA and Japan, covers an alternative method by which central aortic blood pressure may be derived. This confers intellectual property rights to AtCor until December 2024. The patent provides expanded commercial opportunity, adds to AtCor’s growing portfolio of commercially relevant intellectual property.  Full Article

Search Stocks